FDA Begins Review Of Pre-amendments Device Data Submissions
This article was originally published in The Gray Sheet
Executive Summary
A friendly reminder to pre-amendments device makers: failing to submit the safety and effectiveness information FDA ordered on 25 device types this April could result in seizure, injunction or even criminal prosecution
You may also be interested in...
Congress Enters Final Stages On FDA Reform Bill
Legislative leaders say they remain on track to send FDA user fee reauthorization and reform legislation for the president’s signature by the end of June following House passage of bill.
Fireworks Kept At Bay As Congress Pushes To Enact FDA Reforms By July 4
Bipartisan FDA user fee reauthorization and reform legislation sailed unanimously through the House Energy and Commerce Committee May 10, with many similarities to a Senate version that has also passed out of committee.
FDA Panel Endorses PMAs For Electroshock Therapy Devices
A recent vote by an FDA advisory panel favoring more stringent regulation of electroconvulsive therapy devices is not likely to jeopardize future availability of the products on the market, according the panel's chairman.